TriNutra's Standardized Black Seed Oil Enters South Korea Through New Retail Partnership

TriNutra, a supplier of standardized black seed oil, has announced a brand partnership with South Korean supplement company CHAKHAN Co., which has launched a soft gel product called BLACKCUMIN featuring TriNutra's proprietary ThymoQuin ingredient.¹

The product is being distributed in South Korea through DS Medipharm, which holds exclusive distribution rights for ThymoQuin in that market, and is sold through a dedicated BLACKCUMIN website and the Naver Smart Store platform.

For ingredient suppliers and finished product manufacturers, the announcement illustrates a common route branded ingredients take into new international markets, through a local distributor and a retail brand partner rather than direct entry.

"In developing BLACKCUMIN, we wanted to offer consumers a black seed oil product built around purity, consistency and strong scientific research," said Youngchan Kim, CEO of CHAKHAN Co., in the companies' announcement. "When DS Medipharm brought to our attention their exclusive ThymoQuin standardized composition and growing body of research, it made it a perfect fit for what we wanted to bring to consumers in South Korea."

What Distinguishes ThymoQuin From Other Black Seed Oil Ingredients?

TriNutra describes ThymoQuin as a cold-pressed Nigella sativa, or black seed, oil standardized to contain more than 3% thymoquinone, the compound most associated with the plant's studied bioactivity, while limiting free fatty acid content to below 1.25%.¹

The company states its growing, harvesting, and manufacturing processes are designed to preserve the oil's full-spectrum composition and bioavailability, and markets the ingredient as meeting United States Pharmacopeia purity standards, though that standardization applies to the raw ingredient rather than to the finished BLACKCUMIN soft gel, whose independent testing was not addressed in the announcement.

What Does the Published Research on ThymoQuin and Thymoquinone Actually Show?

The announcement states that ThymoQuin has been studied across areas including the gut-stress axis, cardiovascular and metabolic health, blood sugar support, and immune support, though the depth of evidence varies by area.

An 8-week, randomized, placebo-controlled trial published in EC Nutrition found that supplementation with the proprietary black seed oil was associated with lower cortisol, higher DHEA, and improved sleep quality scores in moderately stressed adults, though the publicly available summary does not specify enrollment size or daily dose.²

Evidence for thymoquinone and blood sugar support draws more heavily from Nigella sativa as a plant material broadly rather than from ThymoQuin specifically: a 2020 systematic review and meta-analysis of 50 randomized controlled trials in Phytotherapy Research found Nigella sativa supplementation was associated with reductions in fasting glucose, hemoglobin A1c, total cholesterol, and triglycerides, though the same analysis found no significant effect on inflammatory markers.³

That distinction, between brand-specific clinical data and broader botanical evidence, is relevant for manufacturers evaluating how strongly any single studied ingredient supports a given marketing claim.

How Should Manufacturers Interpret Claims Tied to a Newly Launched Regional Product?

TriNutra's own framing of the partnership centers on ingredient quality and market reach rather than on the BLACKCUMIN product's own performance.

"We are pleased to partner with CHAKHAN as ThymoQuin continues to reach new markets around the world," said Morris Zelkha, chief executive officer of TriNutra, in the announcement. "The launch of BLACKCUMIN reflects a shared focus on providing consumers with the highest branded ingredient quality, efficacy and standardization."¹ That framing describes an ingredient-level standardization and research program rather than a clinical evaluation of the BLACKCUMIN soft gel itself, and the underlying stress-resilience trial has not yet been replicated independently or published in a more widely indexed nutrition journal.

References

1. CHAKHAN Co., Ltd. launches ThymoQuin BLACKCUMIN soft gels: new BLACKCUMIN supplement featuring ThymoQuin expands availability of TriNutra's supplement brand in South Korea. TriNutra. September 15, 2026. Accessed September 15, 2026. Press release provided via email.

2. Talbott SM, Talbott JA. Supplementation with proprietary and patented black seed oil improves stress resilience in moderately stressed adults: an 8-week randomized, placebo-controlled study. EC Nutr. 2026;21(3):01-09.

3. Hallajzadeh J, Milajerdi A, Mobini M, et al. Effects of Nigella sativa on glycemic control, lipid profiles, and biomarkers of inflammatory and oxidative stress: a systematic review and meta-analysis of randomized controlled clinical trials. Phytother Res. 2020;34(10):2586-2608. doi:10.1002/ptr.6708